In vivo magnetic resonance imaging for investigating the development and distribution of experimental brain metastases due to breast cancer1

Translational Oncology

Volumn 5, Issue 3, 2012, Pages 217-225

  Perera, Mevan ^a   Ribot, Emeline J ^a   Percy, Dean B ^a   McFadden, Catherine ^a   Simedrea, Carmen ^b   Palmieri, Diane ^c   Chambers, Ann F ^b,d   Foster, Paula J ^a,d  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN METASTASIS; BRAIN REGION; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL LINE; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; THREE DIMENSIONAL IMAGING;

EID: 84862022432     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.12109     Document Type: Article

References (36)

1. Lockman PR, Mittapalli RK, Taskar KS, Rudraraju V, Gril B, Bohn KA, Adkins CE, Roberts A, Thorsheim HR, Gaasch JA, et al. (2010). Heterogeneous bloodtumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer. Clin Cancer Res 16, 5664-5678.
2. Weil RJ, Palmieri DC, Bronder JL, Stark AM, and Steeg PS (2005). Breast cancer metastasis to the central nervous system. Am J Pathol 167, 913-920.
3. Lin NU, Bellon JR, and Winer EP (2004). CNS metastases in breast cancer. J Clin Oncol 22, 3608-3617.
4. DiStefano A, Yong Yap Y, Hortobagyi GN, and Blumenschein GR (1979). The natural history of breast cancer patients with brain metastases. Cancer 44, 1913-1918.
5. Kamar FG and Posner JB (2010). Brain metastases. Semin Neurol 30, 217-235.
6. Bendell JC, Domchek SM, Burstein HJ, Harris L, Younger J, Kuter I, Bunnell C, Rue M, Gelman R, and Winer E (2003). Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer 97, 2972-2977.
7. Pestalozzi BC, Zahrieh D, Price KN, Holmberg SB, Lindtner J, Collins J, Crivellari D, Fey MF, Murray E, Pagani O, et al. (2006). Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann Oncol 17, 935-944.
8. Church DN, Modgil R, Guglani S, Bahl A, Hopkins K, Braybrooke JP, Blair P, and Price CGA (2008). Extended survival in women with brain metastases from HER2 overexpressing breast cancer. Am J Clin Oncol 31, 250-254.
9. Stemmler HJ, Kahlert S, Siekiera W, Untchb M, Heinrichc B, and Heinemann V (2006). Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer. Breast 15, 219-225.
10. Baculi RH, Suki S, Nisbett J, Leeds N, and Groves M (2001). Meningeal carcinomatosis from breast carcinoma responsive to trastuzumab. J Clin Oncol 19, 3297-3298.
11. Yoneda T, Williams PJ, Hiraga T, Niewolna M, and Nishimura R (2001). A bone-seeking clone exhibits different biological properties from the MDAMB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 16, 1486-1495.
12. Chen EI, Hewel J, Krueger JS, Tiraby C, Weber MR, Kralli A, Becker K, Yates JR, and Felding-Habermann B (2007). Adaptation of energy metabolism in breast cancer brain metastases. Cancer Res 67, 1472-1486.
13. Kim LS, Huang S, Lu W, Chelouche Lev D, and Price JE (2004). Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice. Clin Exp Metastasis 21, 107-118.
14. Palmieri D, Lockman PR, Thomas FC, Hua E, Herring J, Hargrave E, JohnsonM, Flores N, Qian Y, Vega-Valle E, et al. (2009). Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA doublestrand breaks. Clin Cancer Res 15, 6148-6157.
15. Tsai MS, Shamon-Taylor LA, Mehmi I, Tang CK, and Lupu R (2003). Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer. Oncogene 22, 761-768.
16. Yano S, Shinohara H, Herbst RS, Kuniyasu H, Bucana CD, Ellis LM, Davis DW, McConkey DJ, and Fidler IJ (2000). Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis. Cancer Res 60, 4959-4967.
17. Thomas FC, Taskar K, Rudraraju V, Goda S, Thorsheim HR, Gaasch JA, Mittapalli RK, Palmieri D, Steeg PS, Lockman PR, et al. (2009). Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer. Pharm Res 26, 2486-2494.
18. Lunt SJ, Cawthorne C, Ali M, Telfer BA, Babur M, Smigova A, Julyan PJ, Price PM, Stratford IJ, Bloomer WD, et al. (2010). The hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy. Br J Cancer 103, 201-208.
19. Palmieri D, Bronder JL, Herring JM, Yoneda T, Weil RJ, Stark AM, Kurek R, Vega-Valle E, Feigenbaum L, Halverson D, et al. (2007). Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain. Cancer Res 67, 4190-4198.
20. Heyn C, Ronald JA, Ramadan SS, Snir JA, Barry AM, MacKenzie LT, Mikulis DJ, Palmieri D, Bronder JL, Steeg PS, et al. (2006). In vivo MRI of cancer cell fate at the single cell level in a mouse model of breast cancer metastasis to the brain. Magn Reson Med 56, 1001-1010.
21. Bernas LM, Foster PJ, and Rutt BK (2010). Imaging iron loaded mouse glioma tumors with bSSFP at 3T. Magn Reson Med 64, 23-31.
22. Ribot EJ, Martinez-Santiesteban FM, Simedrea C, Steeg PS, Chambers AF, Rutt BK, and Foster PJ (2011). In vivo single scan detection of both ironlabeled cells and breast cancer metastases in the mouse brain using balanced steady-state free precession imaging at 1.5 T. J Magn Res Imaging 34, 231-238.
23. Camp RL, Dolled-Filhart M, King BL, and Rimm DL (2003). Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome. Cancer Res 63, 1445-1448.
24. Hicks DG, Short SM, Prescott NL, Tarr SM, Coleman KA, Yoder BJ, Crowe JP, Choueiri TK, Dawson AE, Budd GT, et al. (2006). Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR. Am J Surg Pathol 30, 1097-1104.
25. Tandon AK, Clark GM, Chamness GC, Ullrich A, and McGuire WL (1989). HER-2/neu oncogene protein and prognosis in breast cancer. J Clin Oncol 7, 1120-1128.
26. Andrews PJD and Citerio G (2004). Intracranial pressure. Part one: historical overview and basic concepts. Intensive Care Med 30, 1730-1733.
27. Kuang Y, Nagy JD, and Elser JJ (2004). Biological stoichiometry of tumor dynamics: mathematical models and analysis. Disc Cont Dyn Syst Ser B 4, 221-240.
28. Fitzgerald DP, Palmieri D, Hua E, Hargrave E, Herring JM, Qian Y, Vega-Valle E, Weil RJ, Stark AM, Vortmeyer AO, et al. (2008). Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization. Clin Exp Metastasis 25, 799-810.
29. Percy DB, Ribot EJ, Chen Y, McFadden C, Simedrea C, Steeg PS, Chambers AF, and Foster PJ (2011). In vivo characterization of changing blood-tumor barrier permeability in a mouse model of breast cancer metastasis. A complementary magnetic resonance imaging approach. Invest Radiol 46, 718-725.
30. Song HT, Jordan EK, Lewis BK, Liu W, Ganjei J, Klaunberg B, Despres D, Palmieri D, and Frank JA (2009). Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation. J Transl Med 7, 88.
31. Heyn C, Ronald JA, Mackenzie LT, MacDonald IC, Chambers AF, Rutt BK, and Foster PJ (2006). In vivo magnetic resonance imaging of single cells in mouse brain with optical validation. Magn Reson Med 55, 23-29.
32. Hwang TL, Close TP, Grego JM, Brannon WL, and Gonzales F (1996). Predilection of brain metastasis in gray and white matter junction and vascular border zones. Cancer 77, 1551-1555.
33. Uribe S, Beerbaum P, Sangild TS, Rasmusson A, Razavi R, and Schaeffter T (2009). Four-dimensional (4D) flow of the whole heart and great vessels using real-time respiratory self-gating. Magn Reson Med 62, 984-992.
34. Sung K, Lee HL, Hu HH, and Nayak KS (2010). Prediction of myocardial signal during CINE balanced SSFP imaging. Magn Reson Mater Phy 23, 85-91.
35. Pastel DA, Mamourian AC, and Duhaime AC (2009). Internal structure in pineal cysts on high-resolution magnetic resonance imaging: not a sign of malignancy. J Neurosurg Pediatr 4, 81-84.
36. Xie T, Zhang XB, Yun H, Hu F, Yu Y, and Gu Y (2011). 3D-FIESTA MR images are useful in the evaluation of the endoscopic expanded endonasal approach for midline skull-base lesions. Acta Neurochir 153, 12-18.